
Manish Anand, MD
Associate Professor of Clinical
Medical Sciences Building
Room 6201
231 Albert Sabin Way
Cincinnati, Ohio 45267
Phone 513-558-5471
Fax 513-558-4309
Email manish.anand@uc.edu
Education
Medical Degree: Delhi University 2002
Residency in Internal Medicine: Albert Einstein College of Medicine 2009
Fellowship in Nephrology: Thomas Jefferson University 2016
Fellowship in Transplant Nephrology: Vanderbilt University 2016
Certifications
American Board of Internal Medicine (Nephrology) (Certification Date: 11-12-2015 )
American Board of Internal Medicine (Certification Date: 08-12-2009 ) - (Recertification Date: to 10-07-2022 )
Clinical Interests
Nephrology
Specialities
Internal Medicine
Nephrology
Research and Practice Interests
Glomerular Disease in Native & Kidney Transplant
Plasma Exchange
Live Kidney Donor
Antibody Mediated Rehjection
Research Support
Grant: #UCSF PEARL II sub Feinstein Institute sub UH2AR067688 Investigators:Abu Jawdeh, Bassam; Alloway, Rita; Anand, Manish; Tremblay, Simon; Woodle, Ervin Steve 06-01-2018 -05-31-2019 National Institute of Arthritis, Musculoskeletal and Skin Disease Pathway Exploration and Analysis in Renal Lupus (PEARL) – Phase 2 Role:Collaborator $83,271.00 Awarded Level:Federal
Grant: #CVAY736K12301 Investigators:Anand, Manish 06-29-2023 -10-31-2025 Novartis AG A randomized, double-blind, parallel group, placebo-controlled, multicenter phase 3 trial to evaluate the efficacy, safety and tolerability of ianalumab on top of standard-of-care therapy in participa Role:PI 709819.10 Hold Level:Industry
Grant: #CC (2U01DK116097-06) Investigators:Anand, Manish 09-01-2023 -05-31-2028 National Inst of Diabetes and Digestive and Kidney Disease 7/14 APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center Role:PI 10259.00 Hold Level:Federal
Grant: #BGB-3111-309 Investigators:Anand, Manish 09-25-2023 -09-25-2026 BeiGene A Phase 3, Multicenter, Randomized, Active-Controlled, Open-Label Study to Evaluate the Efficacy and Safety of Zanubrutinib in Patients with Primary Membranous Nephropathy Role:PI 328578.75 Hold Level:Industry
Investigators:Anand, Manish 03-04-2024 -03-31-2027 PPD A Phase 3, Randomized, Double-blind, Placebo-controlled Study of BION-1301 in Adults with IgA Nephropathy Role:PI 176250.55 Hold Level:Industry
Investigators:Anand, Manish 06-11-2025 -06-18-2030 Nkarta, Inc. A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with Autoimmune Disease Role:PI 0.00 Hold Level:Industry
Publications
Peer Reviewed Publications
Manish Anand, Ekta Nayyar, Beatrice Concepcion, Megha Salani, Heidi Schaefer (2017). Tuberculosis in Kidney Transplant Recipients: Case Series and Review of Literature. World J Transplant, 7 (3) , 213-221
Manish Anand, Juan Pablo Arroyo, Hassan Alhalabi, Timothy Mayor, Mark Lusco, Anthony Langone, Beatrice P Concepcion (2017). IgA-dominant Acute Post-infectious Glomerulonephritis Presenting as Acute Renal Failure in a Kidney Transplant Recipient. Kidney Internal Reports, 2 (4) , 766-769
Kamal, Mahwash; Govil, Amit; Anand, Manish;Abu Jaweh, Bassam G; Shah, Silvi (2018). Severe BK polyomavirus induced hemorrhagic cystitis in a kidney transplant recipient with absence of renal allograft involvement. Transplant infectious disease, 20 (1)
M. Kamal, S. Apewokin, M. Anand, B.G. Abu Jawdeh, A. Govil, M.M. Sheikh, S. Shah (2017). Late-onset Allograft Aspergillosis in an HIV-positive Renal Transplant Recipient - A case report. Transplantation Proceedings, 49, 1570-1573
Hamrahian, Mehrdad; Mollaee, Mehri; Anand, Manish; Fulop, TiborImpaired glucose metabolism - A potential risk factor for idiopathic nodular glomerulosclerosis. A single center study,. Medical hypotheses, 12 (1) , 95-98
Gudsoorkar P., Anand M., Abu Jawdeh B.G. (2020). APOL1 Genotyping in Potential African American Living Kidney Donors: Utility and Cost-Effectiveness. AM J Nephrology, 51, 116-118
Manish Anand, Jake Nysather, Gregory McGraw, Senu Apewokin, Ruby Khoury, Michael S Grimley, Shalini Bumb, Amit Govil. (2023). Viral Specific T Cell Therapy in Kidney Transplantation Recipients - A single-center experience. Transplant Infectious Disease, 25 (6)
Nada Alachkar, Marco Delsante, Ross S Greenberg, Abbal Koirala, Tarek Alhamad, Manish Anand, Ben Boonpheng, Christopher Blosser, Umberto Maggiore, Serena M Bagnasco (2023). Evaluation of the Modified Oxford Score in Recurrent IgA Nephropathy in North American Kidney Transplant Recipients: The Banff Recurrent Glomerulonephritis Working Group Report. Transplantation, 107 (9) , 2055-2063
Shikha Jaiswal, Manish Anand, Amit Govil (2024). Xenotransplantation: Bridging Organ Shortages with Pioneering Advances. ASN Kidney News
Shahul Valavoor, Manish Anand, Amit Govil (2024). Antibody Mediated Rejection: An Unmastered Area in Kidney Transplantation. Indian J Transplant, 18, 101-108
Contact Information
Academic - Medical Sciences Building
Room 6201
Cincinnati
Ohio, 45267
Phone: 513-558-5471
Fax: 513-558-4309
manish.anand@uc.edu